vTv Therapeutics Inc. (NASDAQ: VTVT) Stock Information | RedChip

vTv Therapeutics Inc. (NASDAQ: VTVT) Listen to this Section


$13.60
+0.2900 ( +2.18% ) 100.1K

vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Itsproduct pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.

Market Data


Open


$13.60

Previous close


$13.31

Volume


100.1K

Market cap


$32.82M

Day range


$13.23 - $14.30

52 week range


$7.38 - $30.99

Insider Ownership Transactions

Total Amount Purchased: -184,952.00 | $ -2,515,347.20

Date Type Amount Purchased Purchaser
2024-06-27 Sale -6000.00 SPIEGELMAN DANIEL K
2024-06-27 Sale -6000.00 BAKER BROS. ADVISORS LP
2024-06-27 Sale -3000.00 Al-Marzooqi Fahed
2024-06-27 Sale -2250.00 Phillips Anne M.
2024-06-13 Sale -4055.00 Al-Marzooqi Fahed
2024-06-13 Sale -89212.00 SEKHRI PAUL J
2024-06-13 Sale -62159.00 Tuch Steven L.
2024-06-13 Sale -3750.00 Phillips Anne M.
2024-06-13 Sale -3750.00 AKKARAJU SRINIVAS
2024-03-07 Sale -4776.00 BAKER BROS. ADVISORS LP

SEC Fillings


Form Type Description Pages Date
10-q Quarterly Reports 64 Aug 08, 2024
8-k 8K-related 15 Aug 08, 2024
8-k 8K-related 14 Jul 26, 2024
8-k 8K-related 13 Jul 02, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
4 Insider transactions 1 Jun 27, 2024
8-k 8K-related 13 Jun 14, 2024
4 Insider transactions 1 Jun 13, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.